Arcturus Therapeutics Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.
Portfolio Pulse from Benzinga Newsdesk
Arcturus Therapeutics Holdings reported worse-than-expected Q2 financial results, leading to a decrease in its share price.
August 08, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Arcturus Therapeutics Holdings' shares are trading lower due to worse-than-expected Q2 financial results.
Arcturus Therapeutics Holdings reported Q2 financial results that were below expectations. This negative news is likely to decrease investor confidence, leading to a drop in the company's share price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100